Get started
Author

Sigrid Hatse

Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs
2000 · Jan Wijnholds, Carla A. A. M. Mol, et al. · Proceedings of the National Academy of Sciences · 478
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
2002 · Sigrid Hatse, Katrien Princen, et al. · FEBS Letters · 448
PDF
AMD3100, a Potent and Specific Antagonist of the Stromal Cell-Derived Factor-1 Chemokine Receptor CXCR4, Inhibits Autoimmune Joint Inflammation in IFN-γ Receptor-Deficient Mice
2001 · Patrick Matthys, Sigrid Hatse, et al. · The Journal of Immunology · 251
PDF
Cancer and Aging: Two Tightly Interconnected Biological Processes
2021 · Lieze Berben, Giuseppe Floris, et al. · Cancers · 235
PDF
CXCL12-CXCR4 Axis in Angiogenesis, Metastasis and Stem Cell Mobilization
2010 · S. Liekens, D. Schols, et al. · Current Pharmaceutical Design · 213
Role of antimetabolites of purine and pyrimidine nucleotide metabolism in tumor cell differentiation
1999 · Sigrid Hatse, Erik De Clercq, et al. · Biochemical Pharmacology · 189
Is cancer biology different in older patients?
2021 · Yannick Van Herck, Annelies Feyaerts, et al. · The Lancet Healthy Longevity · 161
PDF
Mannose-Specific Plant Lectins from the Amaryllidaceae Family Qualify as Efficient Microbicides for Prevention of Human Immunodeficiency Virus Infection
2004 · Jan Balzarini, Sigrid Hatse, et al. · Antimicrobial Agents and Chemotherapy · 157
PDF
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
2023 · Patricia Altea-Manzano, Ginevra Doglioni, et al. · Nature Cancer · 151
PDF
AMD3465, a monomacrocyclic CXCR4 antagonist and potent HIV entry inhibitor
2005 · Sigrid Hatse, Katrien Princen, et al. · Biochemical Pharmacology · 126
PDF
Carbohydrate-binding Agents Cause Deletions of Highly Conserved Glycosylation Sites in HIV GP120
2005 · Jan Balzarini, Kristel Van Laethem, et al. · Journal of Biological Chemistry · 121
PDF
Discovery of Novel Small Molecule Orally Bioavailable C−X−C Chemokine Receptor 4 Antagonists That Are Potent Inhibitors of T-Tropic (X4) HIV-1 Replication
2010 · Renato T. Skerlj, Gary J. Bridger, et al. · Journal of Medicinal Chemistry · 119
Role of MRP4 and MRP5 in biology and chemotherapy
2002 · Janardhan Sampath, Masashi Adachi, et al. · AAPS PharmSci · 117
PDF
Molecular Mechanism of Action of Monocyclam Versus Bicyclam Non-peptide Antagonists in the CXCR4 Chemokine Receptor
2007 · Mette M. Rosenkilde, Lars-Ole Gerlach, et al. · Journal of Biological Chemistry · 115
Mutation of Asp171 and Asp262 of the Chemokine Receptor CXCR4 Impairs Its Coreceptor Function for Human Immunodeficiency Virus-1 Entry and Abrogates the Antagonistic Activity of AMD3100
2001 · Sigrid Hatse, Katrien Princen, et al. · Molecular Pharmacology · 115
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
2024 · Amelie Franken, Michel Bila, et al. · Immunity · 112
PDF
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency
2012 · S. Hatse, D. Lambrechts, et al. · Carcinogenesis · 109
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis
2005 · Bert De Klerck, Lies Geboes, et al. · Arthritis Research & Therapy · 107
PDF
19p13.1 Is a Triple-Negative–Specific Breast Cancer Susceptibility Locus
2012 · Kristen N. Stevens, Zachary Fredericksen, et al. · Cancer Research · 105
PDF
Pradimicin A, a Carbohydrate-Binding Nonpeptidic Lead Compound for Treatment of Infections with Viruses with Highly Glycosylated Envelopes, Such as Human Immunodeficiency Virus
2006 · Jan Balzarini, Kristel Van Laethem, et al. · Journal of Virology · 102
Profile of Resistance of Human Immunodeficiency Virus to Mannose-Specific Plant Lectins
2004 · Jan Balzarini, Kristel Van Laethem, et al. · Journal of Virology · 99
Trial watch: chemotherapy-induced immunogenic cell death in oncology
2023 · Jenny Sprooten, Raquel S. Laureano, et al. · OncoImmunology · 96
PDF
Inhibition of Human Immunodeficiency Virus Replication by a Dual CCR5/CXCR4 Antagonist
2004 · Katrien Princen, Sigrid Hatse, et al. · Journal of Virology · 86
PDF
Evaluating the physiological reserves of older patients with cancer: The value of potential biomarkers of aging?
2013 · Athanasios G. Pallis, Sigrid Hatse, et al. · Journal of Geriatric Oncology · 84
A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry
2000 · Dirk Daelemans, Dominique Schols, et al. · Molecular Pharmacology · 84
PDF
Works count: 249
Citation count: 6,117
H-index: 43
I10-index: 79
Year
Topic
Type